Literature DB >> 21783260

Anxiety during the menopausal transition: a systematic review.

Christina Bryant1, Fiona K Judd, Martha Hickey.   

Abstract

OBJECTIVE: There have been relatively few studies of the relationship between anxiety and menopause. Despite the paucity of clear evidence, some authors have suggested that the menopausal transition is a time of heightened risk for onset or exacerbation of anxiety symptoms. There is also controversy as to whether anxiety predates or is a consequence of hot flashes. The aim of this paper is to examine the evidence as to the relationship between menopause and anxiety, and between anxiety and hot flushes, one of the core symptoms of menopause.
METHOD: A systematic review was undertaken based on literature published between 1960 and 2011, using the Medline, Web of Science and PsychINFO databases. The key terms 'anxiety', 'anxiety symptoms', 'anxiety disorder', 'menopause', 'menopausal transition', 'midlife', 'hot flushes or flashes' and 'vasomotor symptoms' were entered into the search. Studies were included if they reported original research using a clearly described measure of anxiety or investigated the relationship between anxiety and vasomotor symptoms.
RESULTS: Nine studies reporting the relationship between menopause and anxiety, two studies reporting the prevalence of panic disorder, and eight studies investigating the relationship between anxiety and vasomotor symptoms were identified. Overall, anxiety symptom levels were low throughout the menopausal transition, but the studies were characterised by poor measurement of both menopausal status and anxiety symptoms and relied heavily on the use of brief, largely nonvalidated measures of anxiety symptoms, which are of unknown clinical significance. In the studies that also measured factors such as attitude to menopause, and dispositional optimism or changes in family life these emerged as important predictors of vasomotor symptom severity.
CONCLUSIONS: None of the available studies provides solid data on the prevalence of anxiety disorders that meet diagnostic criteria, and the present state of knowledge does not be no justify the inclusion of "menopausal anxiety" as a reproductive-related disorder. With respect to the relationship between hot flashes and anxiety, studies need to ensure that somatic and psychological symptoms are not confounded by the use of unsuitable anxiety measures, and that psychological variables are given serious consideration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21783260     DOI: 10.1016/j.jad.2011.06.055

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort.

Authors:  Ellen W Freeman; Mary D Sammel
Journal:  Menopause       Date:  2016-09       Impact factor: 2.953

2.  Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation.

Authors:  Joyce T Bromberger; Howard M Kravitz; Yuefang Chang; John F Randolph; Nancy E Avis; Ellen B Gold; Karen A Matthews
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

3.  Measuring hot flash phenomenonology using ambulatory prospective digital diaries.

Authors:  William I Fisher; Rebecca C Thurston
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

4.  How well do different measurement modalities estimate the number of vasomotor symptoms? Findings from the Study of Women's Health Across the Nation FLASHES Study.

Authors:  Polly Fu; Karen A Matthews; Rebecca C Thurston
Journal:  Menopause       Date:  2014-02       Impact factor: 2.953

5.  Functional exercise in combination with auricular plaster therapy is more conducive to rehabilitation of menopausal women patients with anxiety disorder.

Authors:  Yubin Han; Fugui Duan; Rongmei Xu; Yi Wang; Hongyu Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model.

Authors:  Lauren M Federici; Izabela Facco Caliman; Andrei I Molosh; Stephanie D Fitz; William A Truitt; Pascal Bonaventure; Janet S Carpenter; Anantha Shekhar; Philip L Johnson
Journal:  Psychoneuroendocrinology       Date:  2015-12-18       Impact factor: 4.905

7.  Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine.

Authors:  Elena M Umland; Laura Falconieri
Journal:  Int J Womens Health       Date:  2012-07-05

Review 8.  Memory Decline in Peri- and Post-menopausal Women: The Potential of Mind-Body Medicine to Improve Cognitive Performance.

Authors:  Jim R Sliwinski; Aimee K Johnson; Gary R Elkins
Journal:  Integr Med Insights       Date:  2014-08-03

9.  Differences in the What's My M3? test between pre- and postmenopausal women.

Authors:  Sebastián Carranza-Lira; Edith Pablo-Cruz
Journal:  Prz Menopauzalny       Date:  2017-10-12

10.  Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause.

Authors:  Marianna de B Jaeger; Camila S Miná; Sofia Alves; Gabriela J Schuh; Maria C Wender; Gisele G Manfro
Journal:  Braz J Psychiatry       Date:  2020-10-09       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.